UNMC 2020 Lymphoma Study Group & Hematology Highlights: A Post ASH Review
CLL Highlights from ASH: Chemo Free Therapy Achieves MRD Clearance, AVO Effective as Frontline Therapy, Time-limited Therapy with Ven+Ritux for R/R Disease
Comments 0
Login to view comments.
Click here to Login
